Filana Therapeutics, Inc.
MX ˙ BMV ˙ US14817C1071
SecurityMX:FLNA / Filana Therapeutics, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Citadel Advisors Llc ownership in FLNA / Filana Therapeutics, Inc.

On February 17, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 0 shares of Filana Therapeutics, Inc. (MX:FLNA) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 13,864 shares of Filana Therapeutics, Inc.. This represents a change in shares of -100.00% during the quarter.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (FLNA) in the form of stock options. The firm currently holds call options representing 237,000 of underlying shares valued at $400,530 USD and put options representing 74,100 of underlying shares valued at $125,229 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:FLNA / Filana Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-17 2025-12-31 13F CASSAVA SCIENCES COM 14817C107 0 -13,864 -100.00 0 -100.00
2025-11-14 2025-09-30 13F CASSAVA SCIENCES COM 14817C107 13,864 13,864 40 0.0000
2025-08-14 2025-06-30 13F CASSAVA SCIENCES COM 14817C107 0 -73 -100.00 0 0.0000
2025-05-15 2025-03-31 13F CASSAVA SCIENCES COM 14817C107 73 73 0 0.0000
2024-11-14 2024-09-30 13F CASSAVA SCIENCES COM 14817C107 0 -37,137 -100.00 0 -100.00
2024-08-14 2024-06-30 13F CASSAVA SCIENCES COM 14817C107 37,137 32,835 763.25 459 426.44 0.0001
2024-05-15 2024-03-31 13F CASSAVA SCIENCES COM 14817C107 4,302 4,302 87 0.0000
2024-02-14 2023-12-31 13F CASSAVA SCIENCES COM 14817C107 0 -8,798 -100.00 0 -100.00
2023-11-14 2023-09-30 13F CASSAVA SCIENCES COM 14817C107 8,798 -143,107 -94.21 146 -96.08 0.0000
2023-08-14 2023-06-30 13F CASSAVA SCIENCES COM 14817C107 151,905 13,648 9.87 3,725 11.70 0.0008
2023-05-15 2023-03-31 13F CASSAVA SCIENCES COM 14817C107 138,257 106,023 328.92 3,335 250.21 0.0007
2023-02-14 2022-12-31 13F CASSAVA SCIENCES COM 14817C107 32,234 32,234 952 0.0002
2022-11-14 2022-09-30 13F CASSAVA SCIENCES COM 14817C107 0 -9,449 -100.00 0 -100.00
2022-08-15 2022-06-30 13F CASSAVA SCIENCES COM 14817C107 9,449 9,449 266 0.0001
2022-02-14 2021-12-31 13F CASSAVA SCIENCES Cmn 14817C107 0 -21,356 -100.00 0 -100.00
2021-11-15 2021-09-30 13F CASSAVA SCIENCES Cmn 14817C107 21,356 -290,182 -93.14 1,326 -95.02 0.0003
2021-08-16 2021-06-30 13F CASSAVA SCIENCES COM 14817C107 311,538 63,809 25.76 26,618 139.05 0.0060
2021-05-21 2021-03-31 13F/A-1 CASSAVA SCIENCES COM 14817C107 247,729 182,351 278.92 11,135 2,396.64 0.0027
2021-05-17 2021-03-31 13F CASSAVA SCIENCES COM 14817C107 247,729 182,351 11,135 0.0027
2021-02-16 2020-12-31 13F CASSAVA SCIENCES COM 14817C107 65,378 36,989 130.29 446 36.39 0.0001
2020-11-16 2020-09-30 13F CASSAVA SCIENCES COM 14817C107 28,389 -94,660 -76.93 327 -13.72 0.0001
2020-08-14 2020-06-30 13F CASSAVA SCIENCES Cmn 14817C107 123,049 105,276 592.34 379 419.18 0.0001
2020-05-15 2020-03-31 13F CASSAVA SCIENCES Cmn 14817C107 17,773 17,773 -85.56 73 -80.74 0.0000
2019-08-14 2019-06-30 13F CASSAVA SCIENCES Cmn 14817C107 0 -20,731 -100.00 0 -100.00
2019-05-15 2019-03-31 13F CASSAVA SCIENCES Cmn 14817C107 20,731 20,731 27 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F FILANA THERAPEUTICS COM Call 237,000 -29.42 401 -39.76 n/a n/a n/a
2026-02-17 2025-12-31 13F CASSAVA SCIENCES COM Call 335,800 -11.63 665 -39.91 n/a n/a n/a
2025-11-14 2025-09-30 13F CASSAVA SCIENCES COM Call 380,000 75.76 1,106 182.61 n/a n/a n/a
2025-08-14 2025-06-30 13F CASSAVA SCIENCES COM Call 216,200 -40.82 391 -28.52 n/a n/a n/a
2025-05-15 2025-03-31 13F CASSAVA SCIENCES COM Call 365,300 -1.83 548 -37.70 n/a n/a n/a
2025-02-14 2024-12-31 13F CASSAVA SCIENCES COM Call 372,100 -29.42 878 -94.34 n/a n/a n/a
2024-11-14 2024-09-30 13F CASSAVA SCIENCES COM Call 527,200 691.59 15,515 1,787.47 n/a n/a n/a
2024-08-14 2024-06-30 13F CASSAVA SCIENCES COM Call 66,600 9.18 823 -33.55 n/a n/a n/a
2024-05-15 2024-03-31 13F CASSAVA SCIENCES COM Call 61,000 -82.83 1,238 -84.53 n/a n/a n/a
2024-02-14 2023-12-31 13F CASSAVA SCIENCES COM Call 355,200 -23.58 7,996 3.37 n/a n/a n/a
2023-11-14 2023-09-30 13F CASSAVA SCIENCES COM Call 464,800 24.08 7,734 -15.80 n/a n/a n/a
2023-08-14 2023-06-30 13F CASSAVA SCIENCES COM Call 374,600 -13.98 9,185 -12.56 n/a n/a n/a
2023-05-15 2023-03-31 13F CASSAVA SCIENCES COM Call 435,500 -39.57 10,504 -50.66 n/a n/a n/a
2023-02-14 2022-12-31 13F CASSAVA SCIENCES COM Call 720,700 -36.41 21,289 -55.09 n/a n/a n/a
2022-11-14 2022-09-30 13F CASSAVA SCIENCES COM Call 1,133,400 24.41 47,399 85.03 n/a n/a n/a
2022-08-15 2022-06-30 13F CASSAVA SCIENCES COM Call 911,000 40.63 25,617 6.48 n/a n/a n/a
2022-05-16 2022-03-31 13F CASSAVA SCIENCES COM Call 647,800 -39.05 24,059 -48.20 n/a n/a n/a
2022-02-14 2021-12-31 13F CASSAVA SCIENCES COM Call 1,062,800 -5.99 46,444 -33.82 n/a n/a n/a
2021-11-15 2021-09-30 13F CASSAVA SCIENCES Cmn Call 1,130,500 383.33 70,181 251.19 n/a n/a n/a
2021-08-16 2021-06-30 13F CASSAVA SCIENCES COM Call 233,900 -14.70 19,984 62.14 n/a n/a n/a
2021-05-21 2021-03-31 13F/A CASSAVA SCIENCES COM Call 274,200 101.03 12,325 1,225.27 n/a n/a n/a
2021-05-17 2021-03-31 13F CASSAVA SCIENCES COM Call 274,200 12,325 n/a n/a n/a
2021-02-16 2020-12-31 13F CASSAVA SCIENCES COM Call 136,400 -38.06 930 -63.31 n/a n/a n/a
2020-11-16 2020-09-30 13F CASSAVA SCIENCES COM Call 220,200 259.80 2,535 1,248.40 n/a n/a n/a
2020-08-14 2020-06-30 13F CASSAVA SCIENCES Cmn Call 61,200 59.38 188 18.99 n/a n/a n/a
2020-05-15 2020-03-31 13F CASSAVA SCIENCES Cmn Call 38,400 158 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F FILANA THERAPEUTICS COM Put 74,100 -46.27 125 -54.21 n/a n/a n/a
2026-02-17 2025-12-31 13F CASSAVA SCIENCES COM Put 137,900 59.61 273 8.76 n/a n/a n/a
2025-11-14 2025-09-30 13F CASSAVA SCIENCES COM Put 86,400 200.00 251 382.69 n/a n/a n/a
2025-08-14 2025-06-30 13F CASSAVA SCIENCES COM Put 28,800 -73.46 52 -67.90 n/a n/a n/a
2025-05-15 2025-03-31 13F CASSAVA SCIENCES COM Put 108,500 -65.97 163 -78.46 n/a n/a n/a
2025-02-14 2024-12-31 13F CASSAVA SCIENCES COM Put 318,800 -35.36 752 -94.82 n/a n/a n/a
2024-11-14 2024-09-30 13F CASSAVA SCIENCES COM Put 493,200 395.18 14,515 1,080.00 n/a n/a n/a
2024-08-14 2024-06-30 13F CASSAVA SCIENCES COM Put 99,600 53.94 1,230 -6.25 n/a n/a n/a
2024-05-15 2024-03-31 13F CASSAVA SCIENCES COM Put 64,700 -57.74 1,313 -61.93 n/a n/a n/a
2024-02-14 2023-12-31 13F CASSAVA SCIENCES COM Put 153,100 -37.18 3,446 -15.02 n/a n/a n/a
2023-11-14 2023-09-30 13F CASSAVA SCIENCES COM Put 243,700 -26.62 4,055 -50.20 n/a n/a n/a
2023-08-14 2023-06-30 13F CASSAVA SCIENCES COM Put 332,100 -37.97 8,143 -36.94 n/a n/a n/a
2023-05-15 2023-03-31 13F CASSAVA SCIENCES COM Put 535,400 10.01 12,914 -10.18 n/a n/a n/a
2023-02-14 2022-12-31 13F CASSAVA SCIENCES COM Put 486,700 -14.01 14,377 -39.26 n/a n/a n/a
2022-11-14 2022-09-30 13F CASSAVA SCIENCES COM Put 566,000 -12.29 23,670 30.44 n/a n/a n/a
2022-08-15 2022-06-30 13F CASSAVA SCIENCES COM Put 645,300 -14.28 18,146 -35.10 n/a n/a n/a
2022-05-16 2022-03-31 13F CASSAVA SCIENCES COM Put 752,800 41.85 27,959 20.55 n/a n/a n/a
2022-02-14 2021-12-31 13F CASSAVA SCIENCES COM Put 530,700 -13.99 23,192 -39.45 n/a n/a n/a
2021-11-15 2021-09-30 13F CASSAVA SCIENCES Cmn Put 617,000 81.42 38,303 31.82 n/a n/a n/a
2021-08-16 2021-06-30 13F CASSAVA SCIENCES COM Put 340,100 41.53 29,058 169.03 n/a n/a n/a
2021-05-21 2021-03-31 13F/A CASSAVA SCIENCES COM Put 240,300 264.09 10,801 2,300.22 n/a n/a n/a
2021-05-17 2021-03-31 13F CASSAVA SCIENCES COM Put 240,300 10,801 n/a n/a n/a
2021-02-16 2020-12-31 13F CASSAVA SCIENCES COM Put 66,000 14.38 450 -32.23 n/a n/a n/a
2020-11-16 2020-09-30 13F CASSAVA SCIENCES COM Put 57,700 -42.93 664 113.50 n/a n/a n/a
2020-08-14 2020-06-30 13F CASSAVA SCIENCES Cmn Put 101,100 311 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.